Benefit of New Taxane Affirmed in Prostate CA (CME/CE) - QualityPoint Technologies
Links shared publicly online about this topic.
- 835total visits
Benefit of New Taxane Affirmed in Prostate CA (CME/CE) - QualityPoint Technologies
(MedPage Today) -- The recently approved chemotherapy agent cabazitaxel (Jevtana) improves overall survival in metastatic, hormone-refractory prostate cancer resistant to docetaxel (Taxotere), researchers affirmed.
View full resource at qualitypointtech.net
Tags: Cancer, Cancer Medication, Chemotherapy, Prostate Cancer, Prostate, Men's Health, Taxotere, Jevtana
Most Recently Shared on September 30, 2010 at 11:24 pm By:
Benefit of New Taxane Affirmed in Prostate CA (CME/CE): (MedPage Today) -- The recently approved chemotherapy agen... http://bit.ly/9hzPK9
Medical News: Benefit of New Taxane Affirmed in Prostate CA - in Oncology/Hematology, Prostate Cancer from MedPage Today
medpagetoday.com — “The recently approved chemotherapy agent cabazitaxel (Jevtana) improves overall survival in metastatic, hormone-refractory prostate cancer resistant to docetaxel (Taxotere), researchers affirmed.” View full resource at medpagetoday.com
Most Recently Shared on September 30, 2010 at 11:56 pm By:
Benefit of New Taxane Affirmed in Prostate CA (CME/CE) http://bit.ly/avKtBy
Advertisement
